Share this NATF page   

Dr. Goldhaber

June President's Letter

NATF has just published its Atrial Fibrillation Action Initiative.  This compendium represents three years of hard work harnessing the skills of more than three dozen key opinion leaders on stroke prevention in atrial fibrillation.... (read more)

Announcements and Updates

 

10thAnniv 

 

NATF 10th Anniversary Celebration

We would like to thank everyone who came out for this inspiring evening at the Mandarin Oriental Hotel to celebrate a decade of fighting blood clots and saving lives through prevention and education! 

For those who were not able to attend, we invite you to watch our 10th Anniversary Celebration video recounting all of the wonderful things NATF has accomplished over the past ten years:

 

 

The American Journal of Medicine published the NATF Atrial Fibrillation Action Initiative consensus document in April 2016.  This document presents usable recommendations on stroke prevention, bleeding risk assessment, and anticoagulation management based off clinical trial data and guideline updates for Afib. Please visit the AFib section of our website to learn more.

 

AHS

Upcoming Events

sumsmall

2016 THROMBOSIS SUMMIT
Saturday, October 1
7:00 AM - 12:00 PM
Fairmont Copley Plaza Hotel, Boston, MA

This special half-day program is designed for physicians, pharmacists, nurses, nurse practitioners, physician assistants,and allied health professionals.  Patients, family members and caregivers are also encouraged to attend.

Earn up to 3.5 CME credits for attendance

Experts in the field of Thrombosis Medicine will share updates from breakthrough research that has been completed over the last year on blood clots including heart attack, stroke as a result of atrial fibrillation, pulmonary embolism, and deep vein thrombosis. 

Three patient survivors of major thrombotic events will provide their perspective, recounting their experience from initial symptoms and diagnosis through treatment to recovery. Reserve your seat now!

Learn More

Register Now

 

 

PE

Massachusetts General Hospital presents:

PULMONARY EMBOLISM

State-of-the-Art and Scientific Update

June 28-29, 2016

Royal Sonesta Boston in Cambridge, MA

Learn more or register at
www.phscpd.org/MGHPulmonaryEmbolism2016


 

 

Thrombosis Education

IMG_5730

DVT/PE TREATMENT OPTIONS

How do healthcare providers decide which treatments are the best option for their patients?  Read this article to find out more about DVT/PE treatment goals, options, risks, and decision-making.  

 

Anticoagulant Comparison Chart

WHICH ANTICOAGULANT IS RIGHT FOR ME?

For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants. View the Chart.

 

About NATF

Patients

Professionals

Events


Membership

Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120


NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum


Web Development by MTC